(Q36616805)

15 August 2017

Long-term protective effect of high-risk human papillomavirus testing in population-based cervical screening (English)

1 reference

15 August 2017

N W J Bulkmans

1

1 reference

15 August 2017

L Rozendaal

2

1 reference

15 August 2017

F J Voorhorst

3

1 reference

15 August 2017

P J F Snijders

4

1 reference

15 August 2017

C J L M Meijer

5

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

92

1 reference

15 August 2017

9

1 reference

15 August 2017

1800-1802

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6602541

15 August 2017

0 references

cites work

Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362030

Cervical cancer screening programmes and policies in 18 European countries

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362030

The predicted effect of changes in cervical screening practice in the UK: results from a modelling study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362030

Negative human papillomavirus testing in normal smears selects a population at low risk for developing high-grade cervical lesions.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362030

The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362030

Management of women who test positive for high-risk types of human papillomavirus: the HART study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362030

PCR based high risk HPV testing is superior to neural network based screening for predicting incident CIN III in women with normal cytology and borderline changes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362030

Assessing gains in diagnostic utility when human papillomavirus testing is used as an adjunct to papanicolaou smear in the triage of women with cervical cytologic abnormalities.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362030

Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2362030

Women who participate in spontaneous screening are not at higher risk for cervical cancer than women who attend programme screening

20 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15827553

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/SJ.BJC.6602541

1 reference

15 August 2017

1 reference

15 August 2017

1 reference